Optimized bioluminescence assay of creatine kinase and creatine kinase B-subunit activity.
Spectrophotometry of CK-B subunit activity based on immunoinhibition is rapid and convenient. However, the low sensitivity limits clinical applications to serum samples with CK-B activities considerably above normal. A sensitive, but not optimized, bioluminescent assay of CK-B, also based on immunoinhibition, has been described. We improved this method by the use of an ADP concentration saturating the CK reaction and by the combined use of AMP and diadenosine pentaphosphate for inhibition of adenylate kinase. The optimized bioluminescent method is similar to the corresponding spectrophotometric method (reaction conditions, analytical procedure, numerical results, etc.) and results by the two methods correlate well. However, the measuring time is shorter and, more important, the sensitivity of the bioluminescent method allows accurate determinations of CK-B, even in serum from healthy individuals (CV approximately 3%). Kits and instrumentation (manual and automatic) for determination of CK and CK-B are now commercially available.
D000262:Adenylyl Cyclases / Q000097:blood; D003402:Creatine Kinase / Q000097:blood* / Q000134:cerebrospinal fluid; D006801:Humans; D007527:Isoenzymes; D008163:Luminescent Measurements; D009135:Muscular Diseases / Q000097:blood; D009203:Myocardial Infarction / Q000097:blood; D011933:Reagent Kits, Diagnostic; D012016:Reference Values; D013053:Spectrophotometry
D007527:Isoenzymes; D011933:Reagent Kits, Diagnostic; D003402:Creatine Kinase; D000262:Adenylyl Cyclases